Pharmafile Logo
Pharmafocus logo
Advanced Search
Affreza image

FDA ‘yes’ to inhaled insulin

June 30, 2014
Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human

The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …

News
GSK China

GSK China sex tape ‘sent to Witty’

June 30, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape

GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …

News
BMS image

CHMP approves six drugs including daclatasvir

June 30, 2014
Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge

A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …

News
catherine_brown_head_of_commercial_quantum_pharmaceutical

Quantum Pharmaceutical adds head of commercial

June 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma

UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …

Appointment
ASCO image

Value tops the agenda at ASCO cancer conference

June 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology

The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …

Feature
Glivec image

NICE U-turn on cancer drug despite price increase

June 27, 2014
Sales and Marketing Cancer, Glivec, NHS, Novartis, gists

UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …

News
astrazeneca image

FDA rejects olaparib

June 27, 2014
Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib

AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …

News
Diovan image

Ranbaxy’s Diovan copycat approved in US

June 27, 2014
Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan

Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …

News
BMS image

BMS expands data transparency

June 27, 2014
Medical Communications, Sales and Marketing BMS, best electronic cigarettes, csr, dcri, transparency

Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …

News
martin_lamb_biotec

Biotec names commercial director

June 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, martin lamb

Clinical trials services firm Biotec Services International has appointed Martin Lamb to the position of commercial director. Lamb will lead …

Appointment
Janssen image

NICE recommends tenth diabetes drug

June 26, 2014
Sales and Marketing Janssen, NHS, diabetes, invokana, type 2

In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …

News
GSK image

FDA warns GSK plant

June 26, 2014
Manufacturing and Production, Sales and Marketing FDA, GSK, Quebec, flu, flulaval, vaccines

GlaxoSmithKline’s Canadian operation has incurred the displeasure of the US Food and Drug Administration for irregularities in its production of …

News

Onyx Health launches women’s health blog

June 26, 2014
Medical Communications A Snapshot of Women’s Health, Onyx, onyx health, women's blog

Healthcare agency Onyx Health has launched its own blog site and online community dedicated to women’s health. In what the …

News
Shire image

AbbVie spells out Shire benefits

June 26, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger

AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …

News
matt_retrogenix

Retrogenix appoints US director



June 26, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britz, retrogenix

Biotech firm Retrogenix has appointed Matthew Britz as its North American business development director.  Britz will operate out of the …

Appointment

Review into NHS cover ups

June 25, 2014
Sales and Marketing CQC, Francis, Hunt, NHS, UK, robert, whistleblowing

Ministers have ordered a review into the whistleblowing culture within the NHS as it’s announced that 20% of hospitals have …

News
Science minister David Willetts image

Willetts champions UK life sciences

June 25, 2014
Research and Development, Sales and Marketing BIA, BIO, Steve Bates, UK, Willetts, life sciences, san diego

Science minister David Willetts has been banging the drum for UK life sciences at a major conference in the US, …

News
seb coe image

Seb Coe: pharma needs to collaborate more

June 25, 2014
Medical Communications, Sales and Marketing ABPI, Open Health, olympic, pharma, seb coe

British Olympic Association chair Sebastian Coe has called on pharma firms to participate more in corporate-sponsored disease prevention projects and …

News
BMS image

New BMS cancer treatment shines

June 25, 2014
Research and Development, Sales and Marketing ASCO, BMS, Cancer, Yervoy, braf, melanoma, nivolumab

Bristol-Myers Squibb’s investigational cancer treatment nivolumab has helped patients with the deadliest form of skin cancer to live longer. The …

News

India ‘likely’ to increase price caps

June 25, 2014
Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing

India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026